工银全球精选股票(QDII)
Search documents
林念2025年三季度表现,工银主题策略混合A基金季度涨幅43.97%
Sou Hu Cai Jing· 2025-10-27 23:31
Group 1 - The core point of the article highlights that fund manager Lin Nian oversees a total of 8 funds, with the best-performing fund being the ICBC Thematic Strategy Mixed A (481015), which achieved a quarterly net value increase of 43.97% by the end of Q3 2025 [1] Group 2 - The ICBC Global Selected Stocks (QDII) fund has a scale of 9.29 billion yuan, with an annualized return of 9.99% and a Q3 2025 increase of 2.52% [2] - The ICBC Thematic Strategy Mixed A fund has a scale of 8.40 billion yuan, with an annualized return of 11.35% and a Q3 2025 increase of 43.97% [2] - The ICBC Global Stocks (QDI) RMB fund has a scale of 4.83 billion yuan, with an annualized return of 7.74% and a Q3 2025 increase of 10.69% [2] - The ICBC Global Stocks (ODII) USD fund has a scale of 4.58 billion yuan, with an annualized return of -31.67% and a Q3 2025 increase of 11.65% [2] - The ICBC Dividend Mixed fund has a scale of 3.41 billion yuan, with an annualized return of 3.25% and a Q3 2025 increase of 16.12% [2] - The ICBC Thematic Strategy Mixed C fund has a scale of 0.17 billion yuan, with an annualized return of -6.09% and a Q3 2025 increase of 43.77% [2] - Lin Nian's management of the ICBC Dividend Mixed fund (481006) has resulted in a cumulative return of 120.68% and an average annualized return of 9.1% during his tenure [2] Group 3 - Lin Nian executed a total of 141 adjustments in heavy stocks during his management period, with 80 profitable adjustments, resulting in a win rate of 56.74% [2] - There were 5 instances of doubling returns, with a multiplier of 3.55% [2] Group 4 - Notable stock adjustments include: - Dongfang Caifu, bought in Q2 2020 and sold in Q3 2021, with an estimated return of 155.53% and a company performance growth of 79% [3][5] - Heng Rui Pharmaceutical, bought in Q4 2018 and sold in Q2 2020, with an estimated return of 96.36% and a company performance growth of 59.23% [7] - Bai Run Co., bought in Q4 2022 and sold in Q1 2024, with an estimated return of -36.61% despite a company performance growth of 37.96% [7]